Evotec, in partnership with the French Medicinal Chemistry Society SCT, is delighted to invite submissions for the “Prize for Excellence in Molecular Design” to be awarded for the third time to an exceptional young to mid-career scientific research talent from academia or industry. The successful candidate will be selected based on outstanding innovation and applied state-of-the-art molecular design skills that have contributed to a demonstrated advance to drug discovery capabilities. In particular, the assessment panel are keen to recognize “drug hunters” who have demonstrated excellence in drug design resulting in highly informative novel molecules that significantly impact a drug discovery project. Submissions preferably should be the subject of a published (or accepted) scientific article, covers a “break-through” discovery or innovative technology/method, and may include the application of machine learning and artificial intelligence (AI).
Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients. The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders. With more than 5000 highly qualified people at 17 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics.
The candidate:
Submission of a report (maximum 5 page) detailing the innovation, including the state-of-art-design, the context and the exceptional added value of the innovation and potential downstream value, any references/publications/patents, and a short CV of the candidate.
Sent as a single file to and before the stated deadline, and named EVOTECPrize_NAME_FirstName.pdf.
On top of the mandatory affiliation to one of the EFMC adhering societies for the year of application, the Award Holder should respect ethical criteria:
The Jury is balanced between Evotec and SCT : 3 representatives from Evotec , 3 representatives from SCT (president, or his/her delegate + 2 other SCT representatives)
The laureate is selected by voting, based on the majority of the votes.
Each member has one vote, except the SCT president who has 2 votes, but the 2 votes cannot be dissociated on 2 applicants.
Evotec Prize for Excellence in Molecular Design Recipients